TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 76nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 530nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 1.68E+3nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 2.11E+3nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 3.21E+3nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 3.43E+4nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
R. C. Patel Institute of Pharmaceutical Education and Research
Curated by ChEMBL
Affinity DataIC50: 7.82E+4nMAssay Description:Inhibition of human EGFR preincubated for 5 mins with substrate followed by ATP addition measured after 30 mins by HTRF methodMore data for this Ligand-Target Pair